// COMPANY
Ajax Therapeutics
SECTOR BIOTECHMENTIONS 5LAST SEEN OCTOBER 16, 2026
// OVERVIEW
Cancer drug developer backed by Goldman Sachs Asset Management, acquired by Eli Lilly.
Discussed in
// RECENT MENTIONS
// SIGNALS
5 SIGNALS
01
funding·StrictlyVC·OCTOBER 16, 2026
Source→02
funding·PitchBook News·OCTOBER 15, 2026
Source→03
m_and_a·Axios Pro Rata·AUGUST 24, 2026
“Abros Therapeutics...agreed to a reverse merger with Werewolf Therapeutics (Nasdaq: HOWL), after having raised $154m from RA Capital Management, Enavate Sciences, and Italy's Abiogen Pharma.”
04
AI-extracted from podcast / newsletter / paper summaries. May contain errors.